To screen or not to screen -- that is the question when it comes to patients at risk for gastric cancer (GC). The symptoms ...

Surgical removal of the tumor is considered the basis for curing stomach cancer. However, 38.8 per cent of patients in Europe (Asia: 60 per cent) suffer a recurrence within two years of the operation.

Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy Philip D. Hardt, MD, PhD; Nils Ewald, MD Disclosures Expert Rev Mol Diagn. 2008;8 (5):579-585. 0 ...

Gastric cancer (GC) is among the most malignant tumors in terms of incidence and mortality. Early diagnosis can improve the survival rate of patients, but there is a lack of effective biomarkers for ...